Overview

Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis

Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The main objective of this study is to evaluate the dose-response relationship of two concentrations of A-101 solution when applied to individual seborrheic keratosis (SK) lesions (target lesions) compared with a matching A-101 Solution Vehicle.
Phase:
Phase 2
Details
Lead Sponsor:
Aclaris Therapeutics, Inc.
Treatments:
Pharmaceutical Solutions